These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 21402668)

  • 21. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W; Briody J; Moore B; Lu PW; Cowell CT
    Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical practice. Idiopathic short stature.
    Lee MM
    N Engl J Med; 2006 Jun; 354(24):2576-82. PubMed ID: 16775237
    [No Abstract]   [Full Text] [Related]  

  • 23. Evaluation of catch-up growth from orthodontic treatment and supplemental growth hormone therapy by using Z-scores.
    Tsuboi Y; Yamashiro T; Ando R; Takano-Yamamoto T
    Am J Orthod Dentofacial Orthop; 2008 Mar; 133(3):450-8. PubMed ID: 18331947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of growth hormone treatment on testicular function, puberty, and adrenarche in boys with non-growth hormone-deficient short stature: a randomized, double-blind, placebo-controlled trial.
    Leschek EW; Troendle JF; Yanovski JA; Rose SR; Bernstein DB; Cutler GB; Baron J
    J Pediatr; 2001 Mar; 138(3):406-10. PubMed ID: 11241051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human growth hormone treatment in short children without growth hormone deficiency.
    Stahnke N
    N Engl J Med; 1984 Apr; 310(14):925-6. PubMed ID: 6700684
    [No Abstract]   [Full Text] [Related]  

  • 26. Absence of catch-down growth in Russell-Silver syndrome after short-term growth hormone treatment.
    Azcona C; Stanhope R
    Horm Res; 1999; 51(1):47-9. PubMed ID: 10095170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature.
    Ranke MB; Lindberg A; Price DA; Darendeliler F; Albertsson-Wikland K; Wilton P; Reiter EO;
    Horm Res; 2007; 68(2):53-62. PubMed ID: 17228181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth hormone responsiveness: peak stimulated growth hormone levels and other variables in idiopathic short stature (ISS): data from the National Cooperative Growth Study.
    Moore WV; Dana K; Frane J; Lippe B
    Pediatr Endocrinol Rev; 2008 Sep; 6(1):5-8. PubMed ID: 18806719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Etiology and patterns of presentation of short stature in Eastern Cape of South Africa.
    Ekpebegh C
    Minerva Endocrinol; 2018 Jun; 43(2):225-227. PubMed ID: 29761686
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment perspectives in idiopathic short stature with a focus on IGF-I deficiency.
    Rosenthal S; Cohen P; Clayton P; Backeljauw P; Bang P; Ten S
    Pediatr Endocrinol Rev; 2007 May; 4 Suppl 2():252-71. PubMed ID: 17581497
    [No Abstract]   [Full Text] [Related]  

  • 31. Use of growth hormone in children.
    Hindmarsh PC; Dattani MT
    Nat Clin Pract Endocrinol Metab; 2006 May; 2(5):260-8. PubMed ID: 16932297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Final height in Swedish children with idiopathic growth hormone deficiency enrolled in KIGS treated optimally with growth hormone.
    Westphal O; Lindberg A;
    Acta Paediatr; 2008 Dec; 97(12):1698-706. PubMed ID: 18976357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concerns, expectations and perception regarding stature, physical appearance and psychosocial functioning before and during high-dose growth hormone treatment of short pre-pubertal children born small for gestational age.
    Lagrou K; Froidecoeur C; Thomas M; Massa G; Beckers D; Craen M; de Beaufort C; Rooman R; François I; Heinrichs C; Lebrethon MC; Thiry-Counson G; Maes M; De Schepper J
    Horm Res; 2008; 69(6):334-42. PubMed ID: 18504392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Should recombinant human growth hormone therapy be used in short small for gestational age children?
    Johnston LB; Savage MO
    Arch Dis Child; 2004 Aug; 89(8):740-4. PubMed ID: 15269075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 50 Years Ago in TheJournalofPediatrics: Treatment of Nonorganic Short Stature: The Quest Continues.
    Dabas A; Gupta P
    J Pediatr; 2021 Dec; 239():58. PubMed ID: 34794644
    [No Abstract]   [Full Text] [Related]  

  • 36. Growth hormone treatment for childhood short stature and risk of stroke in early adulthood; adult stroke risk after growth hormone treatment in childhood: first do no harm.
    Stagnaro S
    Neurology; 2015 Apr; 84(15):1613-4. PubMed ID: 25870454
    [No Abstract]   [Full Text] [Related]  

  • 37. Idiopathic short stature: considerations from the clinic--the viewpoint of the paediatric endocrinologist.
    Kelnar CJ
    Horm Res Paediatr; 2011; 76 Suppl 3():35-7. PubMed ID: 21912160
    [No Abstract]   [Full Text] [Related]  

  • 38. Response to Growth Hormone Treatment in a Patient with Insulin-Like Growth Factor 1 Receptor Deletion.
    Mahmoud R; Naidu A; Risheg H; Kimonis V
    J Clin Res Pediatr Endocrinol; 2017 Dec; 9(4):380-386. PubMed ID: 28720553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth hormone treatment 50 years down the line - are we getting value?
    Hindmarsh PC
    Clin Endocrinol (Oxf); 2012 Jul; 77(1):11-2. PubMed ID: 22404703
    [No Abstract]   [Full Text] [Related]  

  • 40. Growth hormone treatment in patients with hypochondroplasia.
    Regelmann MO; Rapaport R
    Horm Res Paediatr; 2014; 82(6):353-4. PubMed ID: 25531227
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.